Five Prime Therapeutics Obtains $10,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=867b7650-9443-4850-a7a1-dafe58f94013&Preview=1 -
Date
4/20/2012 -
Company Name
Five Prime Therapeutics -
Mailing Address
Two Corporate Dr South San Francisco, CA 94080 -
Company Description
FivePrime is a drug discovery and development company primarily focused on therapeutic proteins. The Company is creating a new paradigm in drug discovery by leveraging the Pharmanome(TM) – the entire set of pharmaceutically relevant genes and proteins. -
Website
http://www.fiveprime.com -
Transaction Type
Venture Equity -
Transaction Amount
$10,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
